Related Experiment Video

Updated: May 13, 2026

Functional Characterization of Endogenously Expressed Human RYR1 Variants
07:59

Functional Characterization of Endogenously Expressed Human RYR1 Variants

Published on: June 9, 2021

Dysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseases

Steven O Marx1, Andrew R Marks

  • 1Division of Cardiology, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA.

Journal of Molecular and Cellular Cardiology
|March 20, 2013
PubMed

Insights

Dysfunctional cardiac ryanodine receptors (RyR2) cause heart failure and arrhythmias due to abnormal calcium signaling. Therapies targeting RyR2 defects show promise in restoring cardiac function and preventing disease progression.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Biochemistry

Background:

  • Calcium-dependent signaling is critical for cardiomyocyte contraction.
  • Cardiac ryanodine receptors (RyR2) are key regulators of calcium release.
  • Dysregulation of RyR2 is implicated in heart failure and arrhythmias.

Purpose of the Study:

  • To review the role of RyR2 in cardiac function and disease.
  • To discuss the impact of altered RyR2 phosphorylation, oxidation, and nitrosylation.
  • To explore therapeutic strategies for RyR2 dysfunction.

Main Methods:

  • Review of existing literature on RyR2 regulation and disease.
  • Discussion of molecular mechanisms of RyR2 modulation by PKA and CaMKII.
  • Examination of genetic and small molecule approaches to correct RyR2 defects.

Main Results:

  • Altered RyR2 phosphorylation, oxidation, and nitrosylation lead to leaky channels.
  • Leaky RyR2 channels cause calcium depletion and impaired excitation-contraction coupling.
  • Genetic and pharmacological interventions can ameliorate RyR2 dysfunction.

Conclusions:

  • RyR2 plays a crucial role in cardiac health and disease.
  • Aberrant RyR2 function contributes to heart failure and arrhythmias.
  • Targeting RyR2 defects offers potential therapeutic benefits for cardiovascular diseases.

More Related Videos

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

Crystal Structure of the N-terminal Domain of Ryanodine Receptor from Plutella xylostella11:31

Crystal Structure of the N-terminal Domain of Ryanodine Receptor from Plutella xylostella

Published on: November 30, 2018

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Dysrhythmias I: Introduction01:15

Dysrhythmias I: Introduction

Dysrhythmias refers to abnormalities in the heart's rhythm. They result from disruptions in the heart's electrical conduction system, which includes the sinoatrial(SA)node, atrioventricular(AV) node, the bundle of His, bundle branches, and Purkinje fibers.Definition and PathophysiologyDysrhythmias result from disorders of impulse formation, impulse conduction, or both. The heart contains specialized cells in the sinoatrial node, atrioventricular node, and the bundle of His and Purkinje fibers...